PDF Cover

Neuroendoscopy Devices Market

The market for Neuroendoscopy Devices was estimated at $444 million in 2025; it is anticipated to increase to $608 million by 2030, with projections indicating growth to around $833 million by 2035.

Report ID:DS1801082
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Neuroendoscopy Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Neuroendoscopy Devices Market Outlook

Revenue, 2025

$444M

Forecast, 2035

$832M

CAGR, 2026 - 2035

6.5%

The Neuroendoscopy Devices industry revenue is expected to be around $443.6 million in 2026 and expected to showcase growth with 6.5% CAGR between 2026 and 2035. As the field of neurosurgery becomes more focused on procedures that have less of an impact on the patient, neuroendoscopy equipment is assuming a more significant role in the neurosurgical workplace, due to surgeons seeking shorter hospital stays and better patient outcomes. Neuroendoscopic procedures which are done either intraventricularly or transnasally account for the majority of the demand for neuroendoscopy equipment, at 76.9% of the current market; this highlights the importance of the neuroendoscopic examination of the brains ventricles and neurosurgery of the skull base. Neuroendoscopes which are rigid have the largest market share, selling $298.56 million in 2025, due to the preference among neurosurgeons for high definition neuroendoscopic devices which can be used in complex neurosurgery. The number of cases of hydrocephalus and also brain tumours is increasing, the population is ageing and imaging, navigation and neuroendoscopic instrument technologies are constantly being improved, all of which means neuroendoscopy equipment will continue to be crucial for neurosurgeons.

The technology of neuroendoscopy, which allows surgeons to see the brain through a minimally invasive endoscope, consists of 3 principal components: neuroendoscopes, cameras and light sources and various surgical instruments. The above technology can be used to treat conditions affecting the brains ventricles and base. Neurosurgeons have used this technology to treat a variety of conditions including hydrocephalus, tumours of the pituitary gland and brain and conditions affecting the base of the skull. Recent improvements in this field include high definition and 3D images, improved compatibility with navigation systems and better imaging during operations. Neurosurgeons are also now more likely to use disposable equipment to reduce the risk of infection, and also to use this technology in centres specialising in neurosurgery. As a result, this technology will be a key factor in making neurosurgery safer, more precise and more efficient.

Neuroendoscopy Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Neuroendoscopy Devices Market Outlook

Market Key Insights

  • The Neuroendoscopy Devices market is projected to grow from $443.6 million in 2025 to $833 million in 2035. This represents a CAGR of 6.5%, reflecting rising demand across Transnasal, Intraventricular, and Transcranial.

  • Among the key players in this market are Visionsense Corporation, Karl Storz and B. Braun. These firms have a significant impact on the markets competitive dynamics.

  • The US and Germany are leading Neuroendoscopy Devices markets and are expected to see growth in the range of 4.2% to 6.2% per annum between 2025 and 2030.

  • The fastest growth rates, of between 7.5 and 9%, are predicted for the emerging markets of India, Brazil and South Africa.

  • A shift towards minimally invasive surgical procedures is driving the value chain in the US and German Neuroendoscopy Devices market. By 2030, this trend is expected to add $18 million to industry revenue.

  • The neuroendoscopy devices market is forecast to expand by 389 million dollars between 2025 and 2035. In this period, neuroendoscopy equipment used for intraventricular and transcranial applications is expected to increase its share of the market.

  • With

    integration of minimally invasive surgical demand with rapid neuroendoscopy technology advancements, and

    Rising Prevalence of Neurological Disorders Increasing Demand for Neuroendoscopy Devices, Neuroendoscopy Devices market to expand 88% between 2025 and 2035.

neuroendoscopy devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Neuroendoscopy Devices - Country Share Analysis

Opportunities in the Neuroendoscopy Devices

Many leading paediatric neurosurgery clinics in Europe are now placing an emphasis on using the least necessary surgical invasion possible to treat ventricles and hydrocephalus which return. Legacy neuroendoscopy devices are often unable- to address the anatomical constraints in infants and children. This is also because they are typically equipped with stiff neuroendoscopes. As neurosurgical techniques improve, neurosurgeons will make use of minimally invasive techniques to treat brain conditions. Neurosurgical techniques that are minimally invasive include ventriculoscopy and cranioscopic resection of brain tumours. Demand will concentrate in special childrens hospitals where technology programmes including data, training and services are bundled together to ensure long term partnerships.

Growth Opportunities in North America and Asia-Pacific

North American neuroendoscopy equipment adoption is very heavily focused on neuroendoscopic methods which are transnasal. It is here that neurosurgeons frequently make use of neuroscopes equipped with both 3D medical imaging and high resolution cameras. Key region's of opportunity include bundling flexible endoscopes with navigation platforms to offer comprehensive minimally invasive neurosurgery equipment portfolios, premium positioning of integrated ventricular endoscopy systems for complex procedures and targeted offerings for outpatient neurosurgical centres. These targeted offerings are expected to lead to faster turnover and lower infection risk. In this medical field, aggressive multinationals and regional manufacturers, who employ the latest technology, are competing fiercely. These companies are pushing high quality image resolution, better product design and cross disciplinary medical treatment as key features. This is increasing the necessity for continuous staff training. This region has robust market fundamentals, driven by high levels of diagnostic testing for conditions of the brain, including conditions of the sinuses. Neurosurgeons in this region have a well established network to refer patients to where treatment is required.
Asia Pacific neuroendoscopy device sales are largely driven by intraventricular procedures. These are especially prevalent in the treatment of hydrocephalus and paediatric neurosurgery, where there is a need for cost effective ventricular endoscopy equipment and robust neurosurgical endoscopes. The most significant opportunities for growth exist in scalable mid range products which are suited for use in difficult sterilization environments, the creation of regional centres where training is given and products serviced to ensure that procedures involving transcranial and intraventricular approaches are conducted in a standardised fashion, and the implementation of a pricing strategy which caters for the needs of public hospitals as well as those private hospitals which are growing in size. The medical equipment market is becoming increasingly fragmented with smaller regional companies now able to compete by using cheaper manufacturing processes and a local distribution network. As a result, companies are having to differentiate their products with quality and long term support, as well as kits designed for specific applications in the treatment of conditions which are accessed through the nose into the brain. There is increasing demand for neurosurgical services in the region due to the development of new hospitals, a growing population and the increasing wealth of the population. Government support for healthcare also increases the number of patients requiring treatment. There is growing awareness of treatments for brain tumours and for conditions affecting the fluid around the brain.

Market Dynamics and Supply Chain

01

Driver: Integration of Minimally Invasive Surgical Demand with Rapid Neuroendoscopy Technology Advancements

The neuroendoscopy devices market is also significantly propelled by the global shift toward minimally invasive neurosurgical procedures and the continuous technological evolution of neuroendoscopy systems. As healthcare providers and patients increasingly prefer procedures that reduce trauma, shorten hospital stays, and lower complication rates, neuroendoscopy’s role in treating conditions like brain tumors and hydrocephalus has also grown markedly. Neuroendoscopic techniques offer these benefits compared with open surgeries, driving broader clinical adoption. Additionally, technological advancements such as high-definition imaging, advanced imaging sensors performance, improved fiber-optic visualization, flexible and miniaturized endoscopes, and integrated navigation systems are also enhancing surgical precision and safety. Innovations including robotics, augmented imaging, and sensor-driven real-time visualization further expand procedural capabilities in complex neurosurgery. The interplay between rising surgical demand for improved patient outcomes and rapid device innovation continues to underpin robust market growth, encouraging healthcare facilities to invest in state-of-the-art neuroendoscopy platforms.
A key driver for the neuroendoscopy devices market is also the increasing global incidence of neurological disorders such as brain tumors, hydrocephalus, and other central nervous system conditions. The growing disease burden, particularly among aging populations, fuels demand for precise diagnostic and therapeutic interventions, making neuroendoscopic procedures essential in neurosurgical care. This trend leads to higher adoption of specialized neuroendoscopy devices by hospitals and surgical centers striving to improve patient outcomes and reduce invasive surgery risks.
02

Restraint: High Capital Costs Combined with Limited Adoption in Resource-Constrained Healthcare Settings

The neuroendoscopy devices market faces persistent challenges from the high capital expenditure required to procure advanced neuroendoscopic systems and the resultant limited adoption in resource-constrained environments. Cutting-edge systems with high-definition imaging, navigation modules, and accessory toolsets often cost hundreds of thousands of dollars, making them financially prohibitive for smaller hospitals and clinics, particularly in developing economies. These barriers restrict revenue growth and constrain device penetration outside well-funded tertiary care centers. The cost burden extends beyond acquisition to include maintenance, sterilization, and periodic component replacement. As a result, many facilities prioritize other surgical technologies with broader procedure volumes, reducing demand for neuroendoscopy devices and slowing overall market expansion. 
03

Opportunity: Rising adoption of Neuroendoscopy Devices in United States ambulatory surgical centers for outpatient brain procedures and Expanding minimally invasive neuroendoscopy for hydrocephalus treatment in India and Southeast Asian neurosurgical hospitals

There is a preference in United States ambulatory surgical centers for procedures involving minimal neurological surgery. This preference is attributed to reduced costs and shorter stays. The increasing use of this technology results in a need for Neuroendoscopy devices that include advanced digital camera tools and the additional equipment needed for outpatient treatment. Neuroendoscopes which can be bent are likely to grow the fastest, specifically for surgery in the skull base or within the brains ventricles. This expansion will be due to global growth from $145 million in 2025 to $219 million by 2030, at a compound annual growth rate of 8.63%. Despite ongoing fragmentation, vendor ASC partnerships and outcome based contracts are the most attractive region.
There remains significant under penetration in the adoption of neuroendoscopy equipment in India and across Southeast Asia, due in part to an increase in the incidence of hydrocephalus and brain tumours. Private hospitals and government institutions are putting money into neurosurgical equipment, with a focus on the used in complex brain operations. Tenders have been advertised for neuroendoscopes. In a global perspective, the market for rigid systems is predicted to reach $298.56 million by the year 2025 and $388.36 million by 2030. The industry is expected to be dominated by the emerging markets. Ventricular endoscopy in adults is expected to be dominated by rigid neuroendoscopy devices.
04

Challenge: Shortage of Specialized Neurosurgeons and Insufficient Training Infrastructure Slowing Clinical Adoption

Another significant restraint in the neuroendoscopy devices market is the limited availability of skilled neurosurgeons trained in endoscopic techniques and the insufficient global training infrastructure. Neuroendoscopic procedures require specialized expertise and a steep learning curve compared with traditional open approaches. Many regions lack comprehensive training programs or simulation centers, constraining the pool of proficient surgeons and limiting procedure volumes. This scarcity directly impacts market dynamics by reducing demand for devices in hospitals where trained personnel are unavailable, and hinders revenue growth for device makers in markets with tighter workforce constraints.

Supply Chain Landscape

1

Optical Components Supply

Visionsense CorporationAckermann Instrumente
2

Neuroendoscopy Devices Manufacturing

KARL STORZB. Braun
3

Neurosurgical Endoscopy Distribution

Clarus MedicalKARL STORZ
4

Minimally Invasive Neurosurgery

HospitalsNeurosurgery DepartmentsAmbulatory Surgical Centers
Neuroendoscopy Devices - Supply Chain

Use Cases of Neuroendoscopy Devices in Transnasal & Transcranial

Transnasal : Transnasal neuroendoscopy provides surgeons with a minimally invasive corridor through the nasal cavity and sphenoid sinus to access skull-base tumors, pituitary lesions, and sinonasal pathologies, significantly reducing the need for traditional craniotomies. Rigid neuroendoscopes with high-definition optics, typically 4–6 mm in diameter, are most commonly used to navigate these narrow anatomical passages, making them ideal for otolaryngologists and neurosurgeons in tertiary hospitals and specialty centers. The transnasal approach offers shorter recovery times, fewer complications, and improved cosmetic outcomes. Key market players such as Karl Storz, B. Braun, Medtronic, Olympus, and Stryker have strong offerings in this segment, leveraging advanced visualization and integrated navigation systems to maintain leading positions in this rapidly evolving application area.
Intraventricular : Intraventricular neuroendoscopy focuses on procedures within the brain’s ventricular system, addressing conditions like hydrocephalus, intraventricular tumors, and cysts. Rigid and flexible neuroendoscopes with diameters between 2–6 mm are widely used, with flexible scopes offering enhanced navigation through curved anatomical pathways. Endoscopic third ventriculostomy (ETV) benefits from precise illumination and irrigation systems, decreasing dependency on shunt placement and improving long-term outcomes. This application is highly prevalent in pediatric and adult neurosurgery departments in major hospitals, driven by superior clinical outcomes and reduced morbidity. Leading manufacturers including Karl Storz, B. Braun, Olympus, and Medtronic continue to innovate in optics and integrated accessory systems to strengthen their market positions.
Transcranial : Transcranial neuroendoscopy involves the endoscopic management of intracranial hematomas, deep-brain tumors, and complex pathologies through small craniotomies, enhancing surgical precision while minimizing collateral tissue disruption. Rigid neuroendoscopes with larger diameters (4–8 mm) are preferred for stable visualization within confined intracranial spaces. This approach enables neurosurgeons in advanced hospital settings to perform minimally invasive procedures that improve neurological outcomes and reduce mortality compared with traditional open surgeries. Market leaders such as Karl Storz, Olympus, B. Braun, and Stryker have competitive portfolios in transcranial systems, often integrating angled optics and advanced imaging for superior intraoperative guidance and clinical reliability.

Recent Developments

Recent developments in neuroendoscopy devices emphasize enhanced imaging, robotic integration, and flexible endoscope innovation to improve surgical accuracy and patient outcomes. A key market trend is the adoption of high-definition visualization and augmented reality navigation systems that streamline minimally invasive brain surgery and reduce operative risks. Leading neurosurgery centers increasingly invest in advanced neuroendoscopic platforms, driving demand for fiber-optic endoscopes, accessory tool kits, and compatible surgical navigation software. This strategic shift strengthens clinical capabilities while expanding precision medicine in neurological interventions.

October 2025 : KARL STORZ successfully received Class III medical device conformity certification for its neurosurgery and neuroendoscopy instruments under the EU Medical Device Regulation, enabling the company to re-offer these products across Europe and CE markets after recertification challenges. This move restores market access and supports revenue growth in a key region.
November 2023 : B. Braun Melsungen introduced its Aesculap neuroendoscopy system featuring enhanced LED illumination and high-definition imaging tailored for pediatric applications such as hydrocephalus and brain tumor procedures. This product development aims to improve clinical outcomes and widen device adoption.
February 2023 : KARL STORZ launched KARL STORZ VentureONE, a new subsidiary dedicated to developing robotic surgery platforms-including those applicable to neuroendoscopy-leveraging AI, virtual reality, and advanced automation to enhance minimally invasive surgical procedures.

Impact of Industry Transitions on the Neuroendoscopy Devices Market

As a core segment of the Medical Device industry, the Neuroendoscopy Devices market develops in line with broader industry shifts. Over recent years, transitions such as Shift Towards Minimally Invasive Procedures and Advancements in Robotic Surgery have redefined priorities across the Medical Device sector, influencing how the Neuroendoscopy Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift Towards Minimally Invasive Procedures

Neuroendoscopy devices are increasingly important in minimally invasive neurosurgery. The US and Germany are region's where growth in this region is expected to be especially strong. Sales of neuroendoscopy devices are expected to increase by $18 million by the year 2030. As neurosurgeons increasingly turn to the benefits offered by endoscopic brain surgery and other neuroendoscopic procedures in their clinics, manufacturers are concentrating on their product lines for neurosurgery. These lines now focus on visualisation equipment and precision neurosurgery instruments. The field is witnessing a significant shift in the value chain, driven by R&D initiatives and greater integration of imaging used during operations. Hospitals are adopting procurement strategies that place an emphasis on technology that minimises invasion. Those companies that adapt their technology development and surgeon training to the minimally invasive technology will be able to capture a disproportionate share of the market and strengthen their market position.
02

Advancements in Robotic Surgery

Advancements in robotic surgery are reshaping the neuroendoscopy devices landscape by significantly enhancing precision, stability, and surgeon control during complex intracranial procedures. Robotic platforms integrated with neuroendoscopes enable tremor filtration, submillimetric movements, and improved access to deep or narrow anatomical regions, reducing operative risk and procedure time. This transition is influencing adjacent industries such as surgical robotics, medical imaging, and navigation software, where demand for interoperable systems and AI assisted guidance is accelerating. For example, robotic arms paired with high definition endoscopic visualization are driving upgrades in imaging sensors and real time data processing. Additionally, hospitals are reallocating capital budgets toward robotic enabled minimally invasive suites, impacting traditional open neurosurgical instrument demand while expanding opportunities across advanced surgical technology ecosystems.